DE69200129D1 - Trisubstituierte Triazine und Pyrimidine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen. - Google Patents

Trisubstituierte Triazine und Pyrimidine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.

Info

Publication number
DE69200129D1
DE69200129D1 DE69200129T DE69200129T DE69200129D1 DE 69200129 D1 DE69200129 D1 DE 69200129D1 DE 69200129 T DE69200129 T DE 69200129T DE 69200129 T DE69200129 T DE 69200129T DE 69200129 D1 DE69200129 D1 DE 69200129D1
Authority
DE
Germany
Prior art keywords
pyrimidines
processes
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69200129T
Other languages
English (en)
Other versions
DE69200129T2 (de
Inventor
Gilbert Regnier
Alain Dhainaut
Ghanem Atassi
Alain Pierre
Stephane Leonce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of DE69200129D1 publication Critical patent/DE69200129D1/de
Publication of DE69200129T2 publication Critical patent/DE69200129T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69200129T 1991-03-07 1992-03-06 Trisubstituierte Triazine und Pyrimidine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen. Expired - Fee Related DE69200129T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9102710A FR2673627B1 (fr) 1991-03-07 1991-03-07 Triazines et pyrimidines trisubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
DE69200129D1 true DE69200129D1 (de) 1994-06-16
DE69200129T2 DE69200129T2 (de) 1994-12-01

Family

ID=9410429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69200129T Expired - Fee Related DE69200129T2 (de) 1991-03-07 1992-03-06 Trisubstituierte Triazine und Pyrimidine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.

Country Status (13)

Country Link
US (1) US5238936A (de)
EP (1) EP0502788B1 (de)
JP (1) JPH0776216B2 (de)
AT (1) ATE105553T1 (de)
AU (1) AU643880B2 (de)
CA (1) CA2062378A1 (de)
DE (1) DE69200129T2 (de)
DK (1) DK0502788T3 (de)
ES (1) ES2056692T3 (de)
FR (1) FR2673627B1 (de)
IE (1) IE66187B1 (de)
NZ (1) NZ241867A (de)
ZA (1) ZA921702B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664594B1 (fr) * 1990-07-11 1992-09-18 Adir Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
AU2599992A (en) * 1991-11-12 1993-06-15 Pfizer Inc. Triazine derivatives for enhancing antitumor activity
US5387685A (en) * 1993-07-16 1995-02-07 American Cyanamid Co MDR reversal agents
EP0916668A4 (de) * 1996-07-29 2000-08-16 Banyu Pharma Co Ltd Chemokin-rezeptor-antagonisten
EP1832655A3 (de) * 1997-04-30 2008-06-18 McGILL UNIVERSITY Verfahren zum Erkennen und Rückgängigmachen von Resistenz gegen makrocyclische Laktonverbindungen
US6403308B1 (en) * 1997-04-30 2002-06-11 Mcgill University Methods for detecting and reversing resistance to macrocyclic lactone compounds
PT1183245E (pt) * 1999-04-22 2007-07-12 Lundbeck & Co As H Antagonistas selectivos de npy (y5)
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6340683B1 (en) * 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US7273880B2 (en) * 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6635633B2 (en) 2000-08-14 2003-10-21 Ortho-Pharmaceutical, Inc. Substituted pyrazoles
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US7223759B2 (en) * 2003-09-15 2007-05-29 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
JP6557674B2 (ja) * 2014-03-12 2019-08-07 ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク 新規クラスのミュー−オピオイド受容体アゴニスト
JP6674542B2 (ja) * 2015-07-30 2020-04-01 四川知本快車創新科技研究院有限公司Ｓｉｃｈｕａｎ Ｋｎｏｗｌｅｄｇｅ Ｅｘｐｒｅｓｓ Ｉｎｓｔｉｔｕｔｅ Ｆｏｒ Ｉｎｎｏｖａｔｉｖｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｃｏ， Ｌｔｄ． 供与体と受容体との間に２つの非共役ブリッジを有する光電変換デバイス用の熱活性化遅延蛍光有機分子
US10844027B2 (en) 2015-09-16 2020-11-24 The Trustees Of Columbia University In The City Of New York Carboxylic diarylthiazepineamines as mu-opioid receptor agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2524467A1 (fr) * 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2525597B1 (fr) * 1982-04-21 1985-06-07 Adir Polymethylene diamines n,n'-substituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2544315B1 (fr) * 1983-04-12 1985-07-05 Adir Polymethylene imines disubstituees, leurs procedes de preparation, et les compositions pharmaceutiques les renfermant
CA2004211A1 (en) * 1988-11-30 1990-05-31 Masataka Syoji Piperidine derivatives and hyportensives containing the same
FR2664594B1 (fr) * 1990-07-11 1992-09-18 Adir Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
JPH05125062A (ja) 1993-05-21
EP0502788B1 (de) 1994-05-11
ATE105553T1 (de) 1994-05-15
ZA921702B (en) 1992-11-25
DE69200129T2 (de) 1994-12-01
IE66187B1 (en) 1995-12-13
JPH0776216B2 (ja) 1995-08-16
CA2062378A1 (fr) 1992-09-08
IE920717A1 (en) 1992-09-09
NZ241867A (en) 1993-02-25
FR2673627A1 (fr) 1992-09-11
AU643880B2 (en) 1993-11-25
FR2673627B1 (fr) 1993-05-07
US5238936A (en) 1993-08-24
DK0502788T3 (da) 1994-09-12
AU1146892A (en) 1992-09-10
ES2056692T3 (es) 1994-10-01
EP0502788A1 (de) 1992-09-09

Similar Documents

Publication Publication Date Title
DE69200129D1 (de) Trisubstituierte Triazine und Pyrimidine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE69214755D1 (de) Thiazolidin-2,4-Dionderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
ATE104279T1 (de) 4-fluorbenzolderivate, herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen.
DE69202313D1 (de) Naphthylethylharnstoff und Naphthylethylthioharnstoff Verbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
ATE10368T1 (de) Uracilderivate, verfahren zu ihrer herstellung und eine diese enthaltende pharmazeutische zubereitung.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE69216221D1 (de) Verbindungen mit guanidin-struktur und diese enthaltende pharmazeutische zusammensetzungen
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE69302829T2 (de) Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
DE69406853T2 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69321861D1 (de) 3-Aminochroman-Spiroderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69201368T2 (de) 1-(Alkoxybenzyl)piperazineamide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DE69422532D1 (de) 2-[4-(4-Azolylbutyl)-1-piperazinyl]-5-hydroxypyrimidin-Derivate, deren Herstellung und deren Verwendung als Heilmittel
NZ238909A (en) Pyrimidine or triazine derivatives, preparation and medicaments thereof
IL79253A (en) Pharmaceutical compositions containing 4-amino-2-(imidazolidin-2-on-1-yl)-5-(3-trifluoromethyl-phenyl-amino-carbonyl)pyrimidines
DE69101097D1 (de) Verwendung von Triazin- und Pyrimidinderivaten zur Herstellung von Arzneimitteln zur Überwindung der Arzneimittelresistenz gegenüber Antikrebs- und Antimalariamittel.
DE69403110D1 (de) Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen
DE69110570D1 (de) Arzneimittel, enthaltend ein N6-substituiertes Adenosin-Derivat zur Behandlung von Hyperlipidämie oder Hypertriglyceridämie.
DE69400283T2 (de) (Cyclohexyl)alkenderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ATE5968T1 (de) 6-substituierte arylpyrido(2,3-d)pyrimidin-7amine, deren derivate und salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
IT1251496B (it) Derivati imidazotiadiazolici ad attivita' diuretica, procedimenti per la loro preparazione e composizioni che li contengono

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee